7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 
      
    		                                                       
      cash flows from operating activities:
    		                                                       
      net income
    		66,638,000 37,052,000 29,730,000 62,160,000 45,762,000 10,833,000 -16,097,000 20,919,000 113,953,000 157,191,000 146,873,000 153,753,000 114,812,000 76,976,000 51,821,000 52,591,000 21,809,000 39,351,000 31,698,000 72,991,000 39,362,000 -47,294,000 68,936,000 116,666,000 31,099,000 10,618,000 2,765,000 709,000 -3,470,000 -3,738,000 -5,128,000 -2,940,000 -6,854,000 -12,093,000 -23,305,000 -13,188,000 -18,756,000 -16,723,000 -18,795,000 -15,783,000 624,000 -603,000 -6,320,000 402,000 813,000 -3,031,000 -6,236,000 -2,810,000 -6,301,000 -6,396,000 -10,406,000 -7,742,000 -8,907,000 -11,385,000 -10,184,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                       
      depreciation and amortization
    		20,218,000 20,085,000 19,915,000 20,665,000 20,103,000 20,484,000 20,137,000 20,841,000 19,448,000 17,828,000 16,591,000 16,009,000 11,961,000 15,247,000 15,558,000 10,972,000 8,313,000 7,596,000 5,558,000 5,353,000 4,765,000 4,141,000 3,844,000 2,568,000 3,857,000 4,122,000 3,572,000 2,717,000 2,481,000 2,193,000 2,276,000 2,241,000 2,180,000 2,255,000 2,328,000 2,599,000 2,651,000 2,708,000 2,680,000 2,835,000 2,650,000 2,522,000 2,532,000 2,255,000 2,102,000 1,992,000 1,910,000 1,859,000 1,753,000 1,709,000 1,660,000 1,630,000 1,487,000 1,366,000 1,085,000 
      amortization
    		                                                       
      benefit from credit losses
    		-30,000                                                       
      asset impairment
    		0 1,538,000 27,000 4,702,000 17,568,000 6,241,000 332,000 9,700,000    0 0                                           
      non-cash interest expense
    		829,000 828,000 1,679,000 2,188,000 2,173,000 2,157,000 2,132,000 2,126,000 2,114,000 2,106,000 2,034,000 2,077,000 2,065,000 2,046,000 1,979,000 12,494,000 12,430,000 12,307,000 7,156,000 5,309,000 5,422,000 5,372,000 2,722,000 1,908,000 1,907,000             28,000 28,000 43,000 40,000 41,000 39,000 227,000 65,000 89,000 102,000 107,000 107,000 107,000 108,000 808,000 66,000   
      net income from change in fair value of debt securities
    		3,174,000                                                       
      stock-based compensation
    		51,469,000 53,896,000 55,633,000 51,830,000 45,940,000 52,757,000 60,833,000 55,222,000 43,814,000 54,166,000 59,655,000 63,645,000 52,296,000 53,064,000 47,797,000 37,176,000 46,954,000 15,312,000 14,844,000 8,289,000 14,399,000 12,300,000 7,515,000 6,176,000 5,776,000 4,934,000 3,290,000 1,521,000 4,051,000 4,289,000 1,571,000 1,450,000 1,727,000 1,621,000 1,929,000 2,087,000 2,532,000 2,708,000 2,999,000 3,117,000 3,283,000 3,308,000 2,988,000 2,703,000 2,530,000 2,494,000 2,013,000 1,894,000 2,045,000 1,475,000 1,435,000 1,607,000 1,451,000 1,002,000 706,000 
      deferred income taxes
    		-1,826,000 403,000 8,560,000 -30,675,000 -5,276,000 -14,076,000 -8,292,000 -5,053,000 -11,499,000 -10,615,000 -16,181,000 -12,099,000 115,000 12,452,000 3,165,000 -2,451,000 1,337,000 5,240,000 -35,367,000 -2,610,000 5,060,000 -7,067,000 -12,500,000                                 
      changes in operating assets and liabilities:
    		                                                       
      accounts receivable
    		-57,980,000 8,681,000 1,760,000 2,684,000 49,414,000 82,183,000 77,359,000 105,771,000 -34,752,000 -3,968,000 -79,529,000 -88,876,000 -46,226,000 51,770,000 -24,224,000 -58,091,000 5,462,000 -44,812,000 -53,719,000 -57,854,000 -32,633,000 6,529,000 49,637,000 -12,606,000 -37,035,000 -15,838,000 -3,266,000 -24,186,000 4,774,000 -3,228,000 9,125,000 3,958,000 -12,671,000 -8,065,000 11,975,000 -1,440,000 -12,372,000 -2,711,000 -1,494,000 28,065,000 -8,252,000 -21,544,000 -751,000 4,151,000 -2,733,000 -18,772,000 3,608,000 2,647,000 -3,277,000 -7,224,000 2,835,000 3,983,000 -22,833,000 3,486,000 4,324,000 
      inventory
    		-15,636,000 -28,991,000 20,979,000 -6,167,000 17,231,000 31,825,000 5,702,000 -39,481,000 -8,003,000 -15,548,000 -855,000 -3,222,000 -16,185,000 -33,830,000 -22,036,000 -5,618,000 -27,648,000 -2,880,000 6,888,000 -4,229,000 -6,349,000 3,430,000 -2,560,000 -1,825,000 -10,137,000 -7,123,000 3,296,000 1,620,000 -416,000 1,071,000 7,457,000 -683,000 -4,477,000 12,969,000 -1,848,000 7,141,000 194,000 6,281,000 -4,776,000 -4,083,000 -2,663,000 692,000 -13,156,000 -6,102,000 236,000 -1,611,000 2,467,000 7,812,000 -6,486,000 4,403,000 -2,466,000 -3,193,000 14,316,000 -5,305,000 -14,433,000 
      prepaid expenses and other assets
    		-78,330,000 -64,261,000 -75,553,000 -16,487,000 -64,149,000 -42,810,000 -10,897,000 -2,401,000 -15,383,000 -20,536,000 -21,457,000 -47,597,000 526,000 -18,310,000 -3,042,000 -8,123,000 -3,568,000 -10,154,000 -5,040,000 -4,185,000 -917,000 -4,525,000 -5,009,000 -5,659,000 934,000 -7,155,000 -2,413,000 865,000 -2,444,000 -512,000 -1,039,000 3,883,000 228,000 -2,224,000 -3,114,000 -902,000 -160,000 -1,635,000 -2,062,000 -273,000 -931,000 -2,008,000 -2,069,000 -680,000 405,000 -1,295,000 -977,000 -481,000 -443,000 -171,000 -355,000 -263,000 869,000 -404,000 -913,000 
      accounts payable, accrued and other liabilities
    		25,494,000 37,212,000 54,232,000 -27,396,000 32,088,000 -23,944,000 -66,284,000 -139,277,000 9,903,000 24,685,000 82,540,000 91,128,000 32,060,000 12,033,000 -1,805,000 45,396,000 24,897,000 10,514,000 36,376,000 44,895,000 26,189,000 -13,323,000 -22,066,000 3,544,000 1,851,000 11,954,000 4,851,000 18,410,000 8,489,000 7,850,000 -11,667,000 -8,129,000 17,158,000 3,351,000 -17,458,000 -5,970,000 -471,000 13,109,000 2,229,000 -7,624,000 -1,708,000 4,407,000 2,305,000 2,687,000     8,681,000 3,933,000 -759,000 3,231,000 -3,176,000 5,497,000 11,222,000 
      warranty obligations
    		4,055,000 2,639,000 10,558,000 8,657,000 7,053,000 15,000 -11,923,000 221,000 8,151,000 34,681,000 14,588,000 25,566,000 9,329,000 12,972,000 9,906,000 5,417,000 7,574,000 5,385,000 8,640,000 2,134,000 5,872,000 406,000 403,000 2,474,000 1,631,000 1,951,000 -252,000 -890,000 542,000 1,017,000 809,000 -536,000 -1,261,000 -381,000 580,000 1,065,000 283,000 407,000 -888,000 -2,259,000 -957,000 -400,000 223,000 1,633,000 -662,000 2,241,000 296,000         
      deferred revenues
    		-3,392,000 -50,813,000 -82,357,000 104,112,000 1,690,000 -1,401,000 -5,554,000 12,611,000 13,369,000 40,715,000 51,085,000 58,331,000 25,764,000 16,033,000 22,061,000 13,859,000 16,399,000 28,469,000 19,440,000 14,011,000 6,262,000 5,689,000 -36,460,000 61,467,000 4,877,000 4,326,000 1,578,000 4,157,000 -3,489,000 -5,611,000 -1,180,000 292,000 1,416,000 2,225,000 1,395,000 2,535,000 2,182,000 2,289,000 4,268,000 2,495,000 2,127,000 2,633,000 2,416,000 1,602,000 2,177,000 1,616,000 -93,000 752,000 2,744,000 1,115,000 976,000 1,550,000 1,238,000 -15,210,000 -6,192,000 
      net cash from operating activities
    		13,918,000 26,629,000 48,414,000 167,292,000 170,138,000 127,062,000 49,201,000 35,450,000 145,855,000 269,243,000 246,232,000 253,714,000 188,010,000 200,650,000 102,443,000 97,173,000 113,354,000 65,660,000 75,841,000 84,180,000 67,501,000 25,431,000 39,222,000 102,271,000 4,961,000 14,772,000 17,063,000 1,875,000 6,816,000 4,080,000 3,361,000 -1,914,000 -2,203,000 186,000 -24,511,000 -4,365,000 -20,597,000 7,258,000 -15,249,000 8,149,000 -6,038,000 -11,773,000 -11,498,000 8,880,000 11,208,000 -147,000 4,281,000 7,579,000 -489,000 -990,000 -6,972,000 7,629,000 -20,429,000 -17,774,000 -14,071,000 
      capex
    		-7,640,000 -7,906,000 -9,546,000 -8,064,000 -7,819,000 -12,526,000 527,000 -20,075,000 -15,975,000 -45,506,000 -12,662,000 -16,429,000 -6,365,000 -10,260,000 -7,275,000 -13,208,000 -12,682,000 -16,428,000 -9,940,000 -8,851,000 -3,903,000 -4,451,000 -3,353,000 -7,420,000 -4,192,000 -2,518,000 -658,000 -1,767,000 -909,000 -432,000 -1,043,000 -512,000 -94,000 -49,000 -3,466,000 -2,560,000 -2,097,000 -4,162,000 -3,348,000 -2,843,000 -4,449,000 -2,307,000 -2,342,000 -2,864,000 -4,887,000 -1,983,000 -1,675,000 -836,000 -1,422,000 -1,970,000 -1,192,000 -1,576,000 -4,321,000 -3,424,000 -2,897,000 
      free cash flows
    		6,278,000 18,723,000 38,868,000 159,228,000 162,319,000 114,536,000 49,728,000 15,375,000 129,880,000 223,737,000 233,570,000 237,285,000 181,645,000 190,390,000 95,168,000 83,965,000 100,672,000 49,232,000 65,901,000 75,329,000 63,598,000 20,980,000 35,869,000 94,851,000 769,000 12,254,000 16,405,000 108,000 5,907,000 3,648,000 2,318,000 -2,426,000 -2,297,000 137,000 -27,977,000 -6,925,000 -22,694,000 3,096,000 -18,597,000 5,306,000 -10,487,000 -14,080,000 -13,840,000 6,016,000 6,321,000 -2,130,000 2,606,000 6,743,000 -1,911,000 -2,960,000 -8,164,000 6,053,000 -24,750,000 -21,198,000 -16,968,000 
      cash flows from investing activities:
    		                                                       
      purchases of property and equipment
    		-8,032,000 -8,259,000 -14,608,000 -8,064,000 -8,533,000 -9,636,000 -7,371,000 -20,075,000 -23,848,000 -44,002,000 -22,476,000 -16,429,000 -8,948,000 -8,691,000 -12,375,000 -13,208,000 -12,682,000 -16,428,000 -9,940,000 -8,851,000 -3,903,000 -4,451,000 -3,353,000 -7,420,000 -4,192,000 -2,518,000 -658,000 -1,767,000 -909,000 -432,000 -1,043,000 -512,000 -94,000 -49,000 -3,466,000 -2,560,000 -2,097,000 -4,162,000 -3,348,000 -2,843,000 -3,422,000 -2,649,000 -3,611,000 -3,413,000 -5,503,000 -2,161,000 -2,172,000 -1,371,000 -1,419,000 -1,785,000 -1,682,000 -1,936,000 -3,041,000 -3,408,000 -4,605,000 
      investment in debt securities
    		                                                       
      investment in tax equity fund
    		-1,408,000 -1,440,000 -6,904,000                                                     
      issuance of loan receivables
    		                                                       
      purchases of marketable securities
    		-116,236,000 -284,306,000 -200,826,000 -93,138,000 -319,190,000 -300,053,000 -472,268,000 -337,757,000 -470,766,000 -577,521,000 -695,387,000 -335,193,000 -512,176,000   -389,466,000                                        
      maturities and sale of marketable securities
    		201,881,000 242,820,000 335,398,000 351,843,000 215,241,000 282,063,000 497,373,000 433,869,000 494,804,000 557,471,000 354,333,000                                             
      net cash from investing activities
    		21,405,000 -51,185,000 113,060,000 250,641,000 -112,482,000 -27,626,000 17,734,000 76,037,000 -14,810,000 -64,052,000 -363,530,000 -118,131,000 -338,001,000 44,491,000 39,735,000 -556,518,000 -536,422,000 -36,428,000 -90,179,000 -13,861,000 -3,903,000 -4,451,000 -3,353,000 -7,420,000 -4,192,000 -2,518,000 -658,000 -7,767,000 -9,909,000 -432,000 -1,043,000 -512,000 -94,000 -49,000 -3,466,000 -1,510,000 -2,097,000 -4,840,000 -3,348,000 -2,780,000 -3,422,000 -2,649,000 -3,611,000 -6,698,000 -5,503,000 -2,161,000 -2,172,000 -1,371,000 -1,419,000 -1,785,000 -1,682,000 -1,936,000 -3,041,000 -3,408,000 -4,605,000 
      cash flows from financing activities:
    		                                                       
      settlement of notes due 2025
    		0 0 -102,168,000                                                     
      proceeds from issuance of common stock under employee equity plans
    		0 5,302,000 67,000 4,719,000 14,000 6,769,000 1,186,000                                                 
      payment of withholding taxes related to net share settlement of equity awards
    		-1,679,000 -2,864,000 -12,110,000 -5,012,000 -6,286,000 -7,473,000 -60,042,000 -27,546,000 -8,465,000 -12,790,000 -71,845,000 -8,100,000 -4,589,000 -5,463,000 -9,344,000 -8,825,000 -3,313,000 -7,813,000 -9,185,000 -16,288,000 -8,390,000 -9,385,000 -34,267,000 -3,760,000                                
      repurchase of common stock
    		0 -29,993,000 -99,964,000 -199,666,000 -49,794,000 -99,908,000 -41,996,000 -99,998,000 -110,000,000       -300,000,000 0                                       
      net cash from financing activities
    		-1,679,000 -27,555,000 -214,175,000 -202,732,000 -56,071,000 -100,612,000 -100,854,000 -114,989,000 -117,746,000 -212,234,000 -71,805,000 -3,010,000 -3,896,000 -1,280,000 -8,940,000 -306,232,000 -3,271,000 -205,757,000 824,671,000 -53,635,000 -9,164,000 -7,594,000 262,071,000 -1,966,000 -3,140,000 115,378,000 -44,422,000 -3,996,000 60,866,000 2,014,000 21,730,000 2,558,000 4,000 149,000 40,586,000 -265,000 38,540,000 -6,946,000 3,046,000 698,000 122,000 19,067,000 677,000 -4,453,000 1,587,000 -64,000 -412,000 125,000 -481,000 326,000 -28,000 -2,170,000 -1,680,000 56,259,000 -973,000 
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-2,300,000 7,557,000 3,675,000                                                     
      net decrease in cash, cash equivalents and restricted cash
    		31,344,000 -44,554,000 -49,026,000                                                     
      cash, cash equivalents and restricted cash — beginning of period
    		0                                                       
      cash, cash equivalents and restricted cash — end of period
    		31,344,000                                                       
      supplemental cash flow disclosure:
    		                                                       
      supplemental disclosures of non-cash investing activities:
    		                                                       
      purchases of property and equipment through tenant improvement allowance
    		0 0 855,000          0 0 748,000                                         
      purchases of property and equipment included in accounts payable
    		392,000 353,000 4,207,000  714,000 -2,890,000 7,898,000  7,873,000 -1,504,000 9,814,000  2,583,000 -1,569,000 4,352,000                          -1,027,000 342,000 1,269,000 549,000 616,000 178,000 497,000 535,000 -3,000 -185,000 490,000 360,000 -1,280,000 -16,000 1,708,000 
      net amortization of premium on marketable securities
    		 -1,234,000 3,512,000                                                     
      benefit for credit losses
    		  62,000                                                     
      net gain from change in fair value of debt securities
    		  -323,000 -3,697,000 741,000 1,931,000 -942,000 -2,670,000                                                
      cash, cash equivalents and restricted cash—beginning of period
    		  464,116,000              0 0 679,379,000 0 0 0 296,109,000                                 
      cash, cash equivalents and restricted cash—end of period
    		  415,090,000                    593,844,000                                 
      net accretion of discount on marketable securities
    		   -7,490,000                                                    
      investments in private companies
    		       0    -15,000,000    0 -13,000,000                                       
      business acquisitions, net of cash acquired
    		           -34,482,000 0 -3,055,000 -24,625,000 -180,413,000 0 0 -55,239,000                                     
      partial settlement of convertible notes
    		   0 -5,000 0 -2,000                                                 
      payment of excise tax on net stock repurchases
    		                                                       
      net increase in cash, cash equivalents and restricted cash
    		                -426,715,000 -176,749,000 809,631,000                                     
      cash and cash equivalents—beginning of period
    		   0 0 0 288,748,000 0 0 0 473,244,000 0 0 0 119,316,000          0 0 106,237,000 0 0 0 29,144,000  0 0 17,764,000  0 0 28,452,000  0 0 42,032,000  0 0 38,190,000  0 0 45,294,000  0 0 51,524,000 
      benefit from doubtful accounts
    		    2,704,000   -129,000 653,000 449,000 180,000 67,000 -79,000 -16,000 147,000 27,000 179,000 257,000 14,000 171,000 69,000 81,000 104,000 -191,000 201,000   43,000 -85,000 153,000 600,000 -435,000 204,000 565,000 142,000 -97,000 1,863,000 794,000 537,000 1,158,000 245,000   0 0 685,000 26,000 13,000 637,000   1,008,000    
      effect of exchange rate changes on cash and cash equivalents
    		    2,638,000 -374,000 -1,177,000 2,175,000 -1,900,000 -326,000 1,904,000 3,088,000 -4,003,000 -238,000 -704,000  -376,000 -224,000 -702,000 903,000 104,000 24,000 -205,000                                 
      net decrease in cash and cash equivalents
    		    4,223,000 -1,550,000 -35,096,000                              15,869,000 -4,773,000 -15,436,000            -8,860,000    -19,621,000 
      cash and cash equivalents—end of period
    		    4,223,000 -1,550,000 253,652,000 -1,327,000 11,399,000 -7,369,000 286,045,000 135,661,000 -157,890,000 243,623,000 251,850,000      54,538,000    -2,913,000 127,872,000 78,087,000 -9,927,000 57,693,000 5,216,000 53,255,000  -2,075,000 998,000 29,955,000  15,869,000 -4,773,000 13,016,000  -9,396,000 4,760,000 27,127,000  6,916,000 -2,314,000 39,935,000  -2,198,000 -2,458,000 36,434,000  -25,252,000 35,066,000 31,903,000 
      net amortization (accretion) of premium (discount) on marketable securities
    		     -1,030,000 2,825,000 -2,950,000 5,094,000                                               
      benefit for doubtful accounts
    		      -130,000                                                 
      loss on partial settlement of convertibles notes
    		               115,000 0 13,000 56,369,000                                     
      deemed repayment of convertible notes attributable to accreted debt discount
    		               -133,000 0 -6,000 -15,579,000                                     
      gain on settlement of debt securities
    		                                                       
      purchase of intangible asset
    		               0                                        
      redemption of investment in private companies
    		                                                       
      issuance of convertible notes, net of issuance costs
    		               0 0 -949,000 1,189,388,000 0 0 -591,000 313,011,000                                 
      purchase of convertible note hedges
    		               0 0 0 -286,235,000 0 0 0 -89,056,000 0 0                               
      sale of warrants
    		               0 0 0 220,800,000 0 0 0 71,552,000 -1,000 0                               
      principal payments and financing fees on debt
    		               -272,000 0 -344,000 -1,078,000 -306,000 -636,000 -485,000 -1,148,000 -197,000 -536,000 -391,000 -44,731,000                             
      partial repurchase of convertible notes
    		               -935,000 0 -79,000 -289,233,000                                     
      proceeds from exercise of equity awards and employee stock purchase plan
    		       12,555,000 719,000 556,000 40,000 5,090,000 693,000 4,183,000 404,000 3,800,000 42,000 3,428,000 214,000 3,687,000 -138,000 2,867,000 1,979,000                                 
      net increase in cash and cash equivalents
    		       -1,327,000 11,399,000 -7,369,000 -187,199,000 135,661,000 -157,890,000 243,623,000 132,534,000      54,538,000    -2,913,000 127,872,000 -28,150,000 -9,927,000 57,693,000 5,216,000 24,111,000 266,000 -2,075,000 998,000 12,191,000     5,961,000   -14,905,000 -2,505,000   1,745,000 6,412,000 -2,198,000       
      supplemental disclosures of non-cash investing and financing activities:
    		                                                       
      net (gain) income from change in fair value of debt securities
    		                                                       
      amortization of marketable securities premiums, net of accretion of purchase
    		          -7,548,000                                             
      change in fair value of debt securities
    		          -1,744,000 -345,000 -519,000 -987,000 1,116,000 111,000 -784,000                                       
      amortization of marketable securities premiums, net of accretion of purchase discounts
    		           -4,723,000                                            
      change in fair value of derivatives
    		                   0 0 59,692,000 -15,344,000                                 
      maturities of marketable securities
    		           282,973,000 184,123,000 116,298,000 76,735,000 0                                        
      contingent consideration in connection with the acquisition
    		                -96,000                                       
      convertible senior note issuance costs included in accounts payable and accrued expense
    		                      591,000                                 
      financing fees on extinguishment of debt
    		                       0 0 0 2,152,000                             
      fees paid for repurchase and exchange of convertible notes due 2023
    		                       0 0                               
      purchases of fixed assets included in accounts payable
    		                2,692,000    496,000 1,051,000 585,000  -268,000 736,000 458,000 770,000                            
      change in fair value of debt security
    		                  -1,437,000                                     
      investment in a private company
    		                  -25,000,000                                     
      cash. cash equivalents and restricted cash—end of period
    		                  1,489,010,000                                     
      loss on partial repurchase of convertibles notes due 2024
    		                                                       
      deemed repayment of convertible notes due 2024 attributable to accreted debt discount
    		                                                       
      intangible assets
    		                           -4,000,000                            
      purchase of investment in private company
    		                                                       
      acquisition
    		                           -6,000,000                            
      proceeds from issuance of common stock, net of issuance costs
    		                           -5,000 -152,000 0 19,923,000  0 -97,000 26,522,000                     
      proceeds from debt, net of issuance costs
    		                                                       
      partial repurchase of convertible notes due 2024
    		                                                       
      accrued interest payable unpaid upon exchange of convertible notes due 2023
    		                        0                               
      net increase in cash, cash equivalents, and restricted cash
    		                      297,735,000                                 
      reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets
    		                                                       
      cash and cash equivalents
    		                      549,144,000                                 
      restricted cash
    		                      44,700,000                                 
      total cash, cash equivalents, and restricted cash
    		                      593,844,000                                 
      issuance of convertible notes due 2024, net of issuance costs
    		                       -68,000 -559,000                               
      payments under revolving credit facility
    		                               0 0 0 -10,100,000 -2,350,000 0 -7,550,000 -7,000,000                 
      proceeds from exercise of equity awards
    		                                                       
      effect of exchange rate changes on cash
    		                        -542,000 240,000 -133,000 -39,000 -80,000 -446,000 63,000 134,000 218,000 712,000 -418,000 -208,000 23,000 -245,000 115,000 -106,000 -58,000 115,000 -473,000 -234,000 -376,000 58,000 48,000 79,000 191,000 -9,000 -178,000 54,000 -102,000 -11,000 28,000 
      acquisition funded by issuance of common stock
    		                           0                            
      acquisition funded by accrued liabilities
    		                                                       
      proceeds from issuance of common stock under employee stock plans
    		                         223,000 309,000 649,000 781,000 1,101,000 269,000 356,000 4,000 168,000 2,000 292,000 43,000 708,000 101,000 1,148,000 122,000 2,067,000 677,000 1,408,000 2,257,000 1,247,000 454,000 757,000 138,000       
      amortization of debt issuance costs
    		                          1,490,000 821,000 747,000 596,000 537,000 336,000 274,000 118,000 945,000 44,000                    
      operating lease, right of use asset
    		                          8,392,000                             
      gain on business divestiture
    		                                                       
      deferred income tax expense
    		                                                       
      purchases of intangible assets
    		                                   0 0                   
      business divestitures
    		                                                       
      proceeds from borrowings under revolving credit facility
    		                                   0 0 0 10,000,000                 
      principal payments on debt
    		                                                       
      cash paid for interest
    		                                               322,000 354,000 327,000 388,000 431,000 346,000 390,000 514,000 
      cash paid for income taxes
    		                                                       
      offering and loan costs included in accrued liabilities
    		                                                       
      asset impairment charges
    		                                                       
      proceeds from debt
    		                            62,772,000 3,271,000 2,309,000                         
      principal payments on term debt
    		                            -2,535,000 -2,358,000 -771,000                         
      warrants issued in connection with debt
    		                                0 0 1,447,000                     
      asset impairment and restructuring
    		                               43,000 -127,000 -155,000 1,920,000                     
      purchases of fixed and intangible assets included in accounts payable
    		                             -5,000 117,000 -320,000 560,000 -998,000 1,309,000 183,000 -421,000 -753,000 1,691,000                 
      deferred debt and offering costs included in accounts payable
    		                                  231,000                     
      operating activities:
    		                                                       
      revaluation of contingent consideration liability
    		                                       -227,000 -700,000 -1,004,000 104,000             
      deferred income tax (benefit) expense
    		                                                       
      changes in operating assets and liabilities
    		                                                       
      investing activities:
    		                                                       
      change in restricted cash
    		                                                       
      financing activities:
    		                                                       
      proceeds from common stock offerings, net of issuance costs
    		                                                       
      holdback payment related to prior acquisition
    		                                                       
      cash and cash equivalents — beginning of year
    		                                                       
      cash and cash equivalents — end of year
    		                                                       
      noncash financing and investing activities:
    		                                                       
      proceeds from term loan
    		                                0 78,000 24,162,000                     
      payments of deferred financing costs
    		                                      -55,000                 
      contingent consideration payment related to prior acquisition
    		                                    0                   
      proceeds from public offering of common stock, net of offering costs
    		                                                       
      proceeds from term loan, net of issuance costs
    		                                                       
      repayments of term loans
    		                                           -5,861,000 -670,000 -1,311,000 -866,000 -632,000 -619,000 -605,000 -591,000 -8,581,000 -1,446,000 -789,000 -3,287,000 
      proceeds from public offering of common stock, net of underwriting fees
    		                                                       
      payments for debt issuance costs and offering costs
    		                                                       
      deferred public offering costs included in accounts payable
    		                                                       
      net income on disposal of assets
    		                                     3,000 25,000 43,000 204,000 84,000 191,000 2,000 219,000 22,000 6,000 0 51,000   10,000 0   
      payments for deferred financing costs
    		                                                       
      acquisition of a business
    		                                                       
      principal payments under capital leases
    		                                               0 0 0 -40,000 0 -33,000 -32,000 -31,000 
      cash and cash equivalents — beginning of period
    		                                                       
      cash and cash equivalents — end of period
    		                                                       
      supplemental disclosures of cash flow information:
    		                                                       
      acquisition-related contingent consideration liability
    		                                                       
      borrowings under revolving credit facility
    		                                        17,000,000               
      payments toward revolving credit facility
    		                                                       
      change in fair value of convertible preferred stock warrants
    		                                                   0 0 103,000 -623,000 
      purchase of patents
    		                                                       
      proceeds from borrowings under term loans
    		                                                       
      payments of financing costs
    		                                                       
      proceeds from issuance of common stock in ipo, net of underwriting discounts and commissions
    		                                                   0 0   
      payment of offering costs
    		                                                   -166,000 -204,000   
      non-cash financing and investing activities:
    		                                                       
      conversion of convertible notes into common stock upon ipo
    		                                                   0 0   
      reclassification of convertible preferred stock warrant liability to additional paid-in capital upon ipo
    		                                                   0 0   
      accounts payable, accrued compensation and other accrued liabilities
    		                                             15,423,000 1,159,000         
      accounts payable, accrued liabilities and warranty obligations
    		                                                       
      proceeds from issuance of convertible notes
    		                                                       
      costs related to issuance of convertible notes
    		                                                       
      proceeds from private placement of common stock
    		                                                       
      assets acquired under capital lease
    		                                                       
      offering costs not yet paid
    		                                                       
      prepayment to supplier
    		                                                       
      proceeds from term loans and debt
    		                                                    0   
      proceeds from the exercise of stock options
    		                                                  603,000  3,000 20,000 24,000 
      proceeds from issuance of convertible preferred stock
    		                                                       
      costs related to issuance of convertible preferred stock
    		                                                       
      term loan and debt issuance costs
    		                                                       
      other financing costs not yet paid
    		                                                       
      noncash interest expense
    		                                                      937,000 
      proceeds from term loans
    		                                                      2,600,000 
      term loan issuance costs
    		                                                       
      deferred offering costs
    		                                                      -279,000 
      deferred offering costs not yet paid
    		                                                      1,753,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.